Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 899

1.

Pharmacists' and technicians' perceptions and attitudes toward dispensing buprenorphine/ naloxone to patients with opioid dependence.

Raisch DW, Fudala PJ, Saxon AJ, Walsh R, Casadonte P, Ling W, Johnson BA, Malkerneker U, Ordorica P, Williford WO, Sather MR.

J Am Pharm Assoc (2003). 2005 Jan-Feb;45(1):23-32.

PMID:
15730114
[PubMed - indexed for MEDLINE]
2.

Pharmacy provision of emergency contraception to men: a survey of pharmacist attitudes in Rhode Island.

Nguyen BT, Zaller N.

J Am Pharm Assoc (2003). 2010 Jan-Feb;50(1):17-23. doi: 10.1331/JAPhA.2010.08183.

PMID:
20097635
[PubMed - indexed for MEDLINE]
3.

The impact of community pharmacy dispensing fees on the introduction of buprenorphine - naloxone in Australia.

Winstock AR, Lea T, Ritter A.

Drug Alcohol Rev. 2007 Jul;26(4):411-6.

PMID:
17564877
[PubMed - indexed for MEDLINE]
4.

Evaluation of e-prescribing in chain community pharmacy: best-practice recommendations.

Rupp MT, Warholak TL.

J Am Pharm Assoc (2003). 2008 May-Jun;48(3):364-70. doi: 10.1331/JAPhA.2008.07031.

PMID:
18595821
[PubMed - indexed for MEDLINE]
5.

Impact of an automated dispensing system in outpatient pharmacies.

Humphries TL, Delate T, Helling DK, Richardson B.

J Am Pharm Assoc (2003). 2008 Nov-Dec;48(6):774-9. doi: 10.1331/JAPhA.2008.07114.

PMID:
19019807
[PubMed - indexed for MEDLINE]
6.

Buprenorphine supply by community pharmacists in Victoria, Australia: perceptions, experiences and key issues identified.

Nielsen S, Dietze P, Dunlop A, Muhleisen P, Lee N, Taylor D.

Drug Alcohol Rev. 2007 Mar;26(2):143-51.

PMID:
17364849
[PubMed - indexed for MEDLINE]
7.

Constructs underlying community pharmacy dispensing functions relative to Florida pharmacy technicians.

Wilson DL, Kimberlin CL, Brushwood DB, Segal R.

J Am Pharm Assoc (2003). 2007 Sep-Oct;47(5):588-98.

PMID:
17848348
[PubMed - indexed for MEDLINE]
8.

Beliefs about medicines among Swedish pharmacy employees.

Jörgensen TM, Andersson KA, Mårdby AC.

Pharm World Sci. 2006 Aug;28(4):233-8. Epub 2006 May 11.

PMID:
16691361
[PubMed - indexed for MEDLINE]
9.

[Substitution treatment for opiate dependence: survey of community pharmacies in Aquitaine].

Jeantaud I, Haramburu F, Bégaud B.

Therapie. 1999 Mar-Apr;54(2):251-5. French.

PMID:
10394262
[PubMed - indexed for MEDLINE]
10.

Opioid dependence treatment, including buprenorphine/naloxone.

Raisch DW, Fye CL, Boardman KD, Sather MR.

Ann Pharmacother. 2002 Feb;36(2):312-21. Review.

PMID:
11847954
[PubMed - indexed for MEDLINE]
11.

Community pharmacies and the provision of opioid substitution services for drug misusers: changes in activity and attitudes of community pharmacists across England 1995-2005.

Sheridan J, Manning V, Ridge G, Mayet S, Strang J.

Addiction. 2007 Nov;102(11):1824-30.

PMID:
17935587
[PubMed - indexed for MEDLINE]
12.

Clinical experience with fortnightly buprenorphine/naloxone versus buprenorphine in Italy: preliminary observational data in an office-based setting.

Amato P.

Clin Drug Investig. 2010;30 Suppl 1:33-9. doi: 10.2165/11536060-000000000-00000.

PMID:
20450244
[PubMed - indexed for MEDLINE]
13.

Importation of prescription medications: experiences, opinions, and intended behaviors of U.S. community pharmacists.

Pickard AS, Nau DP, McKercher PL, Schumock GT.

J Am Pharm Assoc (2003). 2004 Nov-Dec;44(6):666-72.

PMID:
15637849
[PubMed - indexed for MEDLINE]
14.

First insights into community pharmacy based buprenorphine-naloxone dispensing in Finland.

Uosukainen H, Bell JS, Laitinen K, Tacke U, Ilomäki J, Turunen JH.

Int J Drug Policy. 2013 Sep;24(5):492-7. doi: 10.1016/j.drugpo.2013.02.004. Epub 2013 Apr 6.

PMID:
23567099
[PubMed - indexed for MEDLINE]
15.

A system approach to dispensing errors: a national study on perceptions of the Finnish community pharmacists.

Teinilä T, Grönroos V, Airaksinen M.

Pharm World Sci. 2008 Dec;30(6):823-33. doi: 10.1007/s11096-008-9233-4. Epub 2008 Jun 24.

PMID:
18574708
[PubMed - indexed for MEDLINE]
16.

Pharmacy workers' perceptions and acceptance of bar-coded medication technology in a pediatric hospital.

Holden RJ, Brown RL, Scanlon MC, Karsh BT.

Res Social Adm Pharm. 2012 Nov-Dec;8(6):509-22. doi: 10.1016/j.sapharm.2012.01.004. Epub 2012 Mar 13.

PMID:
22417887
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Treating opioid addiction with buprenorphine-naloxone in community-based primary care settings.

Mintzer IL, Eisenberg M, Terra M, MacVane C, Himmelstein DU, Woolhandler S.

Ann Fam Med. 2007 Mar-Apr;5(2):146-50.

PMID:
17389539
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Prescribers' perceptions of the diversion and injection of medication by opioid substitution treatment patients.

Larance B, Degenhardt L, O'Brien S, Lintzeris N, Winstock A, Mattick RP, Bell J, Ali R.

Drug Alcohol Rev. 2011 Nov;30(6):613-20. doi: 10.1111/j.1465-3362.2010.00274.x. Epub 2011 Jan 5.

PMID:
21355939
[PubMed - indexed for MEDLINE]
19.

Community pharmacists' work environments: evidence from the 2004 National Pharmacist Workforce Study.

Kreling DH, Doucette WR, Mott DA, Gaither CA, Pedersen CA, Schommer JC.

J Am Pharm Assoc (2003). 2006 May-Jun;46(3):331-9.

PMID:
16739754
[PubMed - indexed for MEDLINE]
20.

Dispensing opioid substitution treatment: practices, attitudes and intentions of community-based pharmacists.

Lawrinson P, Roche A, Terao H, Le PP.

Drug Alcohol Rev. 2008 Jan;27(1):47-53.

PMID:
18034381
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk